Polarean Imaging says Xenon MRI to be featured prominently at ATS 2025

Polarean Imaging (PLLWF) will be featured at the American Thoracic Society’s (ATS) 2025 Respiratory Innovation Summit, taking place May 16-17 at the Marriott Marquis in San Francisco, California. Polarean will also attend the ATS 2025 International Conference from May 18-21, continuing its active engagement with leaders across pulmonary medicine. Polarean’s selection as a featured company at RIS 2025 underscores the growing recognition of the company’s Xenon MRI platform as an innovative tool for both clinical imaging and pharmaceutical drug development. RIS brings together key innovators, investors, clinicians, and patient advocacy groups for cross-sector dialogue on the future of respiratory care. At the ATS 2025 International Conference, Xenon MRI will be featured in over 30 posters and presentations from more than 10 leading clinical sites. This robust presence reinforces the sustained momentum behind Xenon MRI as a powerful and enduring technology in pulmonary medicine. The breadth and depth of research presented this year further demonstrate its expanding role in both clinical care and clinical trials-signaling that Xenon MRI is not just innovative, but a lasting part of the respiratory care landscape.